FPF
NVO

FNY Partners Fund’s Novo Nordisk NVO Stock Holding History

FNY Partners Fund’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-229,390
Closed -$6.16M – 432
2017
Q4 		$6.16M Buy
229,390
+51,200
+29% +$1.3M 1.02% 26
2017
Q3 		$4.29M Sell
178,190
-160
-0.1% -$3.62K 0.73% 29
2017
Q2 		$3.82M Buy
178,350
+32,550
+22% +$657K 0.93% 23
2017
Q1 		$2.5M Buy
145,800
+125,800
+629% +$2.19M 0.29% 50
2016
Q4 		$359K Buy
+20,000
New +$363K 0.02% 111

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

FNY Partners Fund's NVO Position: Q1 2018 in Review

FNY Partners Fund sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 229,390 shares — an estimated $6.16M sold.

FNY Partners Fund first reported a position in NVO in Q4 2016 and held it in 5 quarters. The position peaked at $6.16M in Q4 2017. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

  • FNY Partners Fund reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
  • FNY Partners Fund sold 229,390 Novo Nordisk shares in Q1 2018, an estimated $6.16M.
  • FNY Partners Fund first reported a position in Novo Nordisk in Q4 2016 and held it in 5 quarters.
  • FNY Partners Fund's Novo Nordisk position peaked at $6.16M in Q4 2017.
  • 553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.